New England Journal of Medicine· 2018Q1· Review
Antibody-Mediated Rejection of Solid-Organ Allografts
- 533citations
- Q1SCImago
- 2018year
Short summary
This review highlights current management strategies for antibody-mediated rejection in solid-organ transplant recipients.
AI-generated from the title and abstract; the full text is not read.
Key points
- Antibody-mediated rejection is a significant challenge in solid-organ transplantation.
- Current management strategies are discussed.
- Advances are leading towards more precise, pathogenesis-based therapies.
- The goal is to improve long-term transplant success.
AI-generated from the title and abstract; the full text is not read.
Abstract
This review focuses on current standards for management of antibody-mediated rejection in solid-organ transplant recipients and emphasizes advances that may ultimately lead to the development of precise, pathogenesis-based therapeutic approaches.
The authors' abstract, as published at the source. New England Journal of Medicine, 2018 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Transplantation
TransplantationMedicine